Table 2.
Prevalence of Hyperuricemia, | Serum Urate Level, Mean (95% CI), | |
---|---|---|
% (95% CI) | mg/dL | |
Overall | 25 (21.3–28.3) | 5.5 (5.3–5.6) |
Men | 26 (22.8–30.0) | 6.1 (5.9–6.3) |
All women | 23 (19.9–26.7) | 4.8 (4.7–5.0) |
Postmenopausal women | 31 (26.8–34.2) | 5.1 (4.8–5.3) |
Age category, y | ||
20–29 | 19 (15.6–22.0) | 5.0 (4.6–5.4) |
30–39 | 22 (18.8–25.6) | 5.2 (5.0–5.5) |
40–49 | 25 (21.5–28.5) | 5.5 (5.2–5.7) |
50–59 | 28 (23.9–31.1) | 5.7 (5.4–6.0) |
60–69 | 30 (25.9–33.3) | 5.8 (5.2–6.5) |
Abbreviation: CI, confidence interval.
Hyperuricemia was defined as serum urate levels >7.0 mg/dL in men and >5.7 mg/dL in women according to National Health and Nutrition Examination Survey criteria.